Medically reviewed by Brian Bezack, DO Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...

LABA and LAMA are used to relieve the symptoms of bronchoconstriction ... AstraZeneca), which are ICS–LABA combinations, are other popular COPD drugs. A major limitation with the current ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary ... have limited capacity to use regular inhalers.

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

The study, involving nearly 394,000 adults, demonstrates that certain diabetes medications may offer unexpected benefits for respiratory health. Global health projections indicate that COPD will ...

A new study suggests COPD patients experience improved lung ... as both can be fearful of losing control of the disease in a change of medication. The CRYSTAL trial is the first large-scale ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...